Procarbazine hydrochloride, an antineoplastic agent, a teratogen, and a carcinogen, was given to a patient with Hodgkin's disease during the first 5 1/2 weeks of her pregnancy, and a normal infant was delivered. Based on past experience with chemotherapeutic agents given to pregnant women with Hodgkin's disease, the authors present a program of management for the pregnant patient with Hodgkin's disease.
No takes yet. Share an insight, caveat, or question.
James H. Wells (1968) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: